113. Bioorg Med Chem Lett. 2018 May 1;28(8):1352-1356. doi:10.1016/j.bmcl.2018.03.008. Epub 2018 Mar 13.A multi-gram-scale stereoselective synthesis of Z-endoxifen.Milroy LG(1), Koning B(2), Scheppingen DSV(3), Jager NGL(4), Beijnen JH(5), Koek J(2), Brunsveld L(3).Author information: (1)Laboratory of Chemical Biology and Institute for Complex Molecular Systems(ICMS), Department of Biomedical Engineering, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands. Electronic address:l.milroy@tue.nl.(2)Syncom B.V., Kadijk 3, 9747 AT Groningen, The Netherlands.(3)Laboratory of Chemical Biology and Institute for Complex Molecular Systems(ICMS), Department of Biomedical Engineering, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.(4)Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute -Antoni van Leeuwenhoek and MC Slotervaart, Louwesweg 6, 1066 EC Amsterdam, TheNetherlands.(5)Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute -Antoni van Leeuwenhoek and MC Slotervaart, Louwesweg 6, 1066 EC Amsterdam, TheNetherlands; Faculty of Science, Division of Pharmacoepidemiology and ClinicalPharmacology, Department of Pharmaceutical Sciences, Utrecht University,Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.Z-Endoxifen is widely regarded as the most active metabolite of tamoxifen, andhas recently demonstrated a 26.3% clinical benefit in a phase I clinical trial totreat metastatic breast cancer after the failure of standard endocrine therapy.Future pharmacological and pre-clinical studies of Z-endoxifen would benefit fromreliable and efficient synthetic access to the drug. Here, we describe a shortand efficient, stereoselective synthesis of Z-endoxifen capable of deliveringmulti-gram (37 g) quantities of the drug in >97% purity with a Z/E ratio >99%after trituration.Copyright © 2018. Published by Elsevier Ltd.DOI: 10.1016/j.bmcl.2018.03.008 PMID: 29548575 